Section

Sequent Scientific hits 52-week high after receiving prequalification approval for Albendazole

By Business Standard - 3 months ago
Sequent Scientific rallied 9.91% to Rs 172.95 after the company has recieved prequalification approval (PQ) from World health Organisation (WHO) for Albendazole, Active Pharmaceutical Ingredient (API).

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.